Physicians' Academy for Cardiovascular Education

Low-dose NOAC after COVID-19 hospitalization in patients with high thrombotic risk

3' education - Jan. 11, 2022 - Prof. Freek Verheugt, MD, PhD

Targeting triglyceride-rich remnant lipoproteins

10' education - Dec. 21, 2021 - Prof. Daniel Gaudet, MD, PhD

Working towards eradication of CV risk

10' education - Dec. 15, 2021 - Prof. Erik Stroes, MD, PhD

A recap of a study on reversal of the effect of P2Y12i

5' education - Dec. 14, 2021 - Prof. Deepak Bhatt, MD

Rethinking responsibilities in the prevention and management of cardiometabolic disease

10' education - Dec. 7, 2021 - Prof. Stephan Jacob, MD

FXIa inhibitor as a promising new anticoagulant drug

3' education - Nov. 23, 2021 - Prof. Jeffrey Weitz, MD

Why focus on triglyceride-rich lipoproteins and their remnants?

10' education - Nov. 23, 2021 - Prof. Henry Ginsberg, MD

Digital transformation in cardiovascular healthcare

3' education - Nov. 22, 2021 - Alexander J. Blood, MD

What is the effect of low-dose aspirin on dementia risk in T2DM?

3' education - Nov. 16, 2021 - Prof. Jane Armitage

No significant improvement of outcomes with EPA in COVID-19

3' education - Nov. 16, 2021 - Rafael Diaz, MD

Rigorous assessment of effect of individual triggers for AF

3' education - Nov. 15, 2021 - Prof. Gregory Marcus, MD

Screening for AF with irregular heart rhythm detection by Fitbit wearables

3' education - Nov. 14, 2021 - Steven Lubitz, MD

Randomized study on effects of coffee consumption on acute physiological changes

3' education - Nov. 14, 2021 - Prof. Gregory Marcus, MD

Ambitious project on use of non-physician providers to control BP

3' education - Nov. 14, 2021 - Prof. Keith Ferdinand, MD

What is the best timing for P2Y12i cessation prior to CABG in patients with ACS?

3' education - Nov. 13, 2021 - Derek So, MD

Interpreting findings of studies on a non-steroidal MRA in T2DM and CKD

10' education - Nov. 9, 2021 - Prof. George Bakris, MD, prof. Betram Pitt, MD and prof. Rajiv Agarwal, MD - Online CME

Panel discussion: Measuring inflammation in the coronary circulation

15' education - Nov. 9, 2021 - Prof. Peter Libby, MD, prof. John Deanfield, MD, and prof. Charalambos Antoniades, MD

Statin therapy in COVID-19 patients

5' education - Nov. 8, 2021 - Prof. Maciej Banach, PhD, MD

Integrating EPA-based therapy in the management of residual CV risk

10' education - Nov. 1, 2021 - Prof. Ph. Gabriel Steg, MD - Online CME

Symposium on the role of SGLT2i in tackling cardiorenal risk in diabetes

15' education - Oct. 28, 2021 - Prof. Melanie Davies, MD and prof. Nikolaus Marx, MD - Online CME

Elevated Lp(a) associated with adverse plaque progression in ASCVD

Literature - Jan. 26, 2022 - Kaiser Y et al. - J Am Coll Cardiol. 2022

A study shows that elevated Lp(a) is independently associated with accelerated progression of low-attenuation plaque in patients with advanced multivessel CAD on guideline-directed preventive therapies.

No reduction of MACE with PCSK9i in patients with a history of HF

Literature - Jan. 25, 2022 - White HD, et al. - Eur Heart J 2021

Although alirocumab reduced LDL-c in patients with or without a history of HF, alirocumab reduced MACE only in patients without HF and not in patients with a history of HF, in an analysis of ODYSSEY OUTCOMES.

Prolonged TV viewing associated with increased VTE risk

Literature - Jan. 24, 2022 - Kunutsor SK, et al. - Eur J Prev Cardiol 2022
A meta-analysis of three observational cohort studies shows that prolonged TV viewing is associated with a higher risk of venous thrombo-embolism (VTE) compared to participants that never or seldom watched TV.

A meta-analysis of three observational cohort studies shows that prolonged TV viewing is associated with a higher risk of venous thrombo-embolism (VTE) compared to participants that never or seldom watched TV.

Subclinical multi-organ affection after recovery from mild to moderate COVID-19

Literature - Jan. 20, 2022 - Petersen EL, et al. - Eur Heart J 2021
A cross-sectional study showed subclinical signs of affection of the pulmonary, cardiac, coagulation and renal systems in mainly non-hospitalized individuals who had mild to moderate SARS-CoV-2 infection ~9 months ago.

A cross-sectional study showed subclinical signs of affection of the pulmonary, cardiac, coagulation and renal systems in mainly non-hospitalized individuals who had mild to moderate SARS-CoV-2 infection ~9 months ago.

Relative fat mass most strongly associated with incident HF risk

Literature - Jan. 18, 2022 - Suthahar N et al. - Sci Rep. 2022

This study investigated the association between multiple indices of adiposity (both novel and established indices) and the risk of incident HF in a community-based cohort.

A guided selection of P2Y12i therapy in ACS patients has most favorable profile

Literature - Jan. 17, 2022 - Galli M, et al. - Eur Heart J 2021
A network meta-analysis of 15 RCTs shows that a guided selection of P2Y12 inhibiting therapy using platelet function or genetic testing is the only strategy associated with a reduction of ischemic events without a trade-off in bleeding in patients with ACS.

A network meta-analysis of 15 RCTs shows that a guided selection of P2Y12 inhibiting therapy using platelet function or genetic testing is the only strategy associated with a reduction of ischemic events without a trade-off in bleeding in patients with ACS.

Anticoagulation reversal in patients with acute bleeding during oral factor Xa inhibitor therapy

Literature - Jan. 17, 2022 - Benz AP et al. - Thromb Haemost. 2022

Andexanet alfa specifically binds and sequesters factor Xa inhibitors. A study investigated the efficacy and safety of andexanet alfa in patients on edoxaban with acute major bleeding.

Consistent benefit of icosapent ethyl across background statin agent and category

Literature - Jan. 12, 2022 - Singh N et al. - J Am Coll Cardiol. 2022

There was no difference of icosapent ethyl efficacy among statin agents and statin categories (lipophilic vs. lipophobic statins) in an exploratory analysis of the REDUCE-IT trial.

Epicardial adipose tissue associated with adverse outcomes in HFmrEF and HFpEF

Literature - Jan. 11, 2022 - Van Woerden G et al. - Circ Heart Fail. 2021

A study shows that epicardial adipose tissue volume is significantly associated with all-cause mortality and HF hospitalization in patients with HFmrEF and HFpEF.

Low-dose NOAC after COVID-19 hospitalization in patients with high thrombotic risk

3' education - Jan. 11, 2022 - Prof. Freek Verheugt, MD, PhD
Anticoagulation after discharge may be necessary for a short time in patients who were hospitalized due to COVID-19 and have a  high thrombotic risk, according to prof. Verheugt.

Anticoagulation after discharge may be necessary for a short time in patients who were hospitalized due to COVID-19 and have a high thrombotic risk, according to prof. Verheugt.

Extended thromboprophylaxis with NOAC after hospitalization for COVID-19 improves outcomes

Literature - Jan. 11, 2022 - Ramacciotti E, et al. - Lancet 2022

The MICHELLE trial shows that extended post-discharge thromboprophylaxis with the NOAC rivaroxaban for 35 days improved clinical outcomes compared to no anticoagulation in patients with high risk of thromboembolism who were hospitalized due to COVID-19.

Online self-assessment to test eligibility for nonprescription statin therapy

Literature - Jan. 4, 2022 - Nissen SE et al. - J Am Coll Cardiol. 2021

A study compared the concordance between participant and clinician assessment of eligibility for rosuvastatin 5 mg using an at-home web-based application.

Agenda